Mamlok Gilad
Transaction: 08/24/2025
OTHER
Change
0
Price
Not reported
Filing
04/27/2026
Type
OTHER
Protalix BioTherapeutics, Inc.
PLX • Biotechnology
$2.67
▲ +0.05 (+2.10%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$221.74M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Manageable debt level · 0.17Healthy liquidity · 2.51Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 13, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.67
Change2.10%
Shares Out83.05M
Market Cap$221.74M
Enterprise Value$171.38M
52W Range1.36 - 3.19
Beta0.01
P/E14.46
P/S2.90
P/B3.30
P/FCF15.15
EV/Sales2.24
Price$2.67
Change2.10%
Shares Out83.05M
Market Cap$221.74M
Enterprise Value$171.38M
52W Range1.36 - 3.19
Beta0.01
P/E14.46
P/S2.90
P/B3.30
P/FCF15.15
EV/Sales2.24
EV/EBITDA8.04
EV/FCF11.71
Earnings Yield6.91%
FCF Yield6.60%
Dividend Yield0.00%
Gross Margin47.85%
Oper. Margin-10.43%
Profit Margin-12.52%
Debt/Eq0.17
Current Ratio2.51
Quick Ratio1.54
Target$6.00
Target Upside124.72%
Target Median$6.00
Target Range6.00 - 6.00
Volume354.69K
Avg Volume744.67K
EPS Surprise0.23
Investment DNA
How strong this company looks for long-term investors
41
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
80/100
Why this score▼
Manageable debt level · 0.17Healthy liquidity · 2.51Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 7 analyst votes · 2026-09-05
86/100
Bullish
Bullish
5
Hold
2
Bearish
0
Price Target
2026-09-05
Low
$6.00
Mean
$6.00
Median
$6.00
High
$6.00
Insider Transactions
Recent executive and insider activity
Bashan Dror
Transaction: 12/19/2025
BUY
Change
+56,000
Price
$1.81
Filing
12/23/2025
Type
BUY
Bar-Shalev Amos
Transaction: 11/18/2025
SELL
Change
-168
Price
$1.87
Filing
11/19/2025
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Mamlok Gilad | OTHER | 0 | Not reported | 08/24/2025 | 04/27/2026 |
| Bashan Dror | BUY | +56,000 | $1.81 | 12/19/2025 | 12/23/2025 |
| Bar-Shalev Amos | SELL | -168 | $1.87 | 11/18/2025 | 11/19/2025 |
| Bashan Dror | BUY | +340,000 | $1.64 | 09/03/2025 | 09/04/2025 |
| Bashan Dror | BUY | +195,000 | Not reported | 09/03/2025 | 09/04/2025 |
| Naos Yaron | BUY | +50,000 | $1.64 | 09/03/2025 | 09/04/2025 |
| Naos Yaron | BUY | +25,000 | Not reported | 09/03/2025 | 09/04/2025 |
| Bar-Shalev Amos | BUY | +7,500 | Not reported | 09/03/2025 | 09/04/2025 |
| Bar-Shalev Amos | BUY | +15,000 | $1.64 | 09/03/2025 | 09/04/2025 |
| Ben Zvi Shmuel | BUY | +7,500 | Not reported | 09/03/2025 | 09/04/2025 |
| Ben Zvi Shmuel | BUY | +15,000 | $1.64 | 09/03/2025 | 09/04/2025 |
| Schwartz Aharon | BUY | +7,500 | Not reported | 09/03/2025 | 09/04/2025 |
| Elze Christian | BUY | +7,500 | Not reported | 09/03/2025 | 09/04/2025 |
| Schwartz Aharon | BUY | +15,000 | $1.64 | 09/03/2025 | 09/04/2025 |
| Elze Christian | BUY | +15,000 | $1.64 | 09/03/2025 | 09/04/2025 |
| Boudes Pol F | BUY | +7,500 | Not reported | 09/03/2025 | 09/04/2025 |
| Boudes Pol F | BUY | +15,000 | $1.64 | 09/03/2025 | 09/04/2025 |
| Melincoff Gwen A | BUY | +7,500 | Not reported | 09/03/2025 | 09/04/2025 |
| Forster Eliot | BUY | +7,500 | Not reported | 09/03/2025 | 09/04/2025 |
| Forster Eliot | BUY | +15,000 | $1.64 | 09/03/2025 | 09/04/2025 |